Aerovate Therapeutics Return on Investment 2020-2025 | JBIO
Current and historical return on investment (ROI) values for Aerovate Therapeutics (JBIO) over the last 10 years.
| Aerovate Therapeutics ROI - Return on Investment Historical Data |
| Date |
TTM Net Income |
LT Investments & Debt |
Return on Investment |
| 2025-03-31 |
$-0.05B |
|
0.00% |
| 2024-12-31 |
$-0.07B |
|
0.00% |
| 2024-09-30 |
$-0.09B |
|
0.00% |
| 2024-06-30 |
$-0.09B |
|
0.00% |
| 2024-03-31 |
$-0.09B |
|
0.00% |
| 2023-12-31 |
$-0.08B |
|
0.00% |
| 2023-09-30 |
$-0.08B |
|
0.00% |
| 2023-06-30 |
$-0.07B |
|
0.00% |
| 2023-03-31 |
$-0.06B |
|
0.00% |
| 2022-12-31 |
$-0.05B |
|
0.00% |
| 2022-09-30 |
$-0.05B |
|
0.00% |
| 2022-06-30 |
$-0.04B |
|
0.00% |
| 2022-03-31 |
$-0.03B |
|
0.00% |
| 2021-12-31 |
$-0.02B |
|
0.00% |
| 2021-09-30 |
$-0.02B |
|
0.00% |
| 2021-06-30 |
$-0.02B |
|
0.00% |
| 2021-03-31 |
$-0.01B |
|
0.00% |
| 2020-12-31 |
$-0.01B |
|
0.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.008B |
$0.000B |
|
Aerovate Therapeutics Inc. is a clinical stage biopharmaceutical company. It focused on developing drugs for cardiopulmonary disease. The company's product pipeline consist AV-101. Aerovate Therapeutics Inc. is based in BOSTON.
|
